sandoz
ActiveSummary
sandoz has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €16.8m and a net result of €3.2m. Equity is growing by about 11% per year across the filed financial years. Its solvency ranks better than 33% of 6,030 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Group and network
Connections & network
4 connected companiesThis company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
PharmaScan BeLux
via Dries Pattyn · Director
→
former→
medicines for europe
Shared director
→
NOVARTIS PHARMA
Shared director
→